Agenda

8 NOV 2018

*Programme subject to change

08:45 - Delegate Registration, Expo & Surgeries

Exhibition takes place in Foyer and Exeter 2, Surgeries in Drake Suite

09:30 - Conference Chair Introduction

Speaker: Doris-Ann Williams MBE, Chief Executive, BIVDA

09:40 - Keynote Address - UK AMR Diagnostics Collaborative

Speaker: Fiona Carragher, Deputy Chief Scientific Officer, NHS England - Confirmed

9.50 - How diagnostics can drive efficiency within the NHS

Speaker: Professor Tim Evans, Director of Clinical & Workforce Productivity, NHS Improvement - Confirmed

10.05 – Using Pathology networks to drive efficient patient care

Speaker: David Wells, Head of Pathology Services Consolidation, NHS Improvements - Confirmed

10:20 - A partnered development of a circulating tumour ESR1 Mutation Test for the detection of metastatic breast cancer mutations indicative of resistance to endocrine hormone therapy

Speaker: Ciaran Fulton, Head of Diagnostics, Centre for Diagnostics Development (CDD), LifeArc - Confirmed

10:35 - Smartphone-enabled point of care testing - transforming the way we approach diagnosis and treatment

Speaker: Dr Neil Polwart, Novarum Founder, BBI Group Head of Mobile

As mobile technology has an ever increasing impact on our lives the permeation of mobile technology into diagnosis and treatment of disease is almost inevitable.Whilst there are many ways to envisage point of care tests integrating with mobile phones, we will describe our patent protected approach to detecting, analysing and interpreting low cost simple to use diagnostic devices for use outside traditional clinical laboratories.

In addition to describing case studies for projects covering a range of applications including infectious disease and monitoring chronic conditions, we will outline a vision for how smartphone connected point of care testing can be used to introduce improved antimicrobial stewardship.

10:50 - Panel Debate- How do we create a diagnostic pathway for the UK

Chair: Daniel Berman, Longitude Prize, Challenge Prize Centre, Nesta - Confirmed

Panelist: Doris-Ann Williams, Chief Executive, BIVDA - Confirmed

Panelist: Fiona Carragher, Deputy Chief Scientific Officer, NHS England - Confirmed

Panelist: Professor Tim Evans, National Director for Clinical Productivity, NHS Improvement - Invited

11:20 - Refreshments, Expo & Surgeries

11:40 - Diagnostics in action- Workshop Breakout session 1-Delegates choose 1 stream from each workshop session

Essex Suite- Stream 1 - Improvement in the quality and reproducibility of diagnostic assays

This presentation will address the application of reference materials measuring quality linked to a primary physical reference “the International Standard”, wherever possible, can provide assurance of the quality of the data and, in turn, support improved clinical management of patients.

Speaker: Clare Morris, Senior Scientist, NIBSC

Grenville Suite-Stream 2 - Improving clinician confidence and decision making in the management of patients over 65 presenting with acute frailty syndromes

This presentation will address a project which with the addition of a diagnostic tool facilitated improved decision making, earlier identification of illness and better patient management.

Speaker: Melinda McPherson, Trainee Advanced Clinical Practitioner, South central Ambulance Service

Exeter 1-Stream 3 - Case Study & Sponsor Required- Apply via abstract section

12.10- Diagnostics in action- Workshop Breakout session 2

Exeter 1-Stream 4- BiomArker-guided Duration of Antibiotic treatment in hospitalised PaTients with suspected Sepsis: the ADAPT-Sepsis Trial

This presentation will explore a recent UK-wide multi-centre randomised controlled trial to determine whether a treatment protocol based on monitoring CRP or PCT safely allow a reduction in duration of antibiotic therapy in hospitalised adult patients with suspected sepsis

Speaker: Professor Paul Dark, Chair of Critical Care Medicine, Manchester University NHS Foundation Trust and Northern NHS Care Alliance - Confirmed

Essex Suite-Stream 5 - Creating a pathway for POC Diagnostics

Speaker: Lisa Harrison,Marketing Director Region North Europe,Abbott-Confirmed

Exeter 1-Stream 6 - Case Study & Sponsor Required- Apply via abstract section

12:45 - Lunch, Expo,Poster Session & Surgeries

Overcoming the challenges and progressing the Diagnostics landscape

14:00 - In-Vitro diagnostic regulations, challenges and opportunities in a post-Brexit UK

Speaker: Alison Dennis, Partner, Fieldfisher - Confirmed

14:00 - Designing the right assay

Speaker: Rachel McKendry, Professor, Biomedical Nanotechnology, London Centre for Nanotechnology, UK - Confirmed

14:20 -CASE STUDY: Real-world evaluation and implementation of a diagnostic test for pre-eclampsia

Speakers: Julie Hart & Guy Checketts

Pre-eclampsia (PE) is a multisystem hypertensive disorder that affects 3-5% of all pregnancies. The disease is a serious cause of maternal and foetal morbidity in the UK and clinical teams therefore have a high degree of suspicion for the disease and a low threshold for admitting pregnant women with suspected PE

Oxford AHSN has been leading a project with Roche Diagnostics and clinicians in the Oxford AHSN region to evaluate and implement the Elecsys® test as part of a new clinical pathway to reduce patient risk in maternity units. This case study highlights the challenges and benefits of introducing a new clinical pathway and the importance of conducting a robust real world evaluation to facilitate implementation.

14:40 -CASE STUDY: Transforming care Pathways

Speaker: TBC

15:00 -CASE STUDY: Making the business case for Diagnostics within your organisation